K. Dyke

发表

V. Castranova, Joseph K. H. Ma, G. Carter, 1984, Inflammation.

Luminescence Immunoassay and Molecular Applications

K. Dyke, R. V. Dyke, 1990 .

L-Arginine and Nitric Oxide Level amongPregnant Women in Sokoto, Nigeria

K. Dyke, O. Erhabor, Hashimu Bello Bunza, 2018 .

The Effects of Conjugated Linoleic Acid and Berberine Supplementation on Markers of Allopurinol Activated Oxidative Stress in Broiler Chickens

K. Barnes, H. Klandorf, K. Dyke, 2021, Medical Research Archives.

Luminol-dependent chemiluminescence analysis of human platelets

V. Castranova, D. Peden, E. P. Brestel, 1980 .

Human Immunodeficiency Viral Disease

R. Bendayan, K. Dyke, Michelle D. Furler, 2008 .

INHIBITORY EFFECT OF TETRANDRINE AND PACLITAXEL OR DOXORUBICIN ON MULTI-DRUG-RESISTANT (MDR) CANCER CELLS ASSOCIATED WITH MDR-ATPASE

K. Dyke, P. Chávez, Arturo J. Sosa, 2014 .

Reversal of Multiple Drug Resistance (MDR) in Malaria by Reverse Isomers of Calcium Channel Blockers and its Possible Application to Cancer and MDR Parasitic Diseases

C. Dyke, K. Dyke, Z. Ye, 1993 .

Oxidative and Nitrosative Stresses: Their Role in Health and Disease in Man and Birds

H. Klandorf, K. Dyke, 2012 .

An Improved Prevention and Treatment of Parkinson's Disease - A Review Considering Recent Findings in Genetics with Helpful Treatments

K. Dyke, 2018 .

Serum Nitric Oxide Levels among Pre- School Children of African Descent with Malaria in Sokoto, Nigeria

K. Dyke, Erhabor Osaro, N. Jiya, 2017 .

Lucigenin chemiluminescence assay as an adjunctive tool for assessment of various stages of inflammation: A study of quiescent inflammatory cells

V. Vallyathan, K. Dyke, Shaily Patel, 2003, Journal of Biosciences.

Impairment of leukocyte myeloperoxidase bactericidal mechanisms with ketamine (Ketalar®)

D. Peden, K. Dyke, G. Pekoe, 2005, Agents and Actions.

Chemiluminescence and Bioluminescence Analysis: Fundamentals and Biomedical Applications

W. Seitz, K. Dyke, K. van Dyke, 1981 .

Three model systems measure oxidation/nitration damage caused by peroxynitrite

M. Reasor, K. Dyke, P. McConnell, 2003, Journal of Biosciences.

A Deadly Mistake in Treatment of Parkinson's Disease

K. Dyke, 2018 .

Use of Chemiluminescence Assays to Monitor the Surface Characteristics and Biological Reactivity of Freshly Fractured vs Aged Silica

V. Castranova, N. Dalal, V. Vallyathan, 1989 .

[37] Cellular chemiluminescence associated with disease states

C. Dyke, K. Dyke, 1986 .

The measurement of chemiluminescence, aggregation, and 5-hydroxy-6,8,11,14-eicosatetraenoic acid production of n-formyl-methioninyl-leucyl-phenylalanine-stimulated human polymorphonuclear leukocytes

V. Castranova, D. Peden, K. Dyke, 1985 .

Attenuation of acute inflammatory effects of silica in rat lung by 21-aminosteroid, U74389G

J. Antonini, M. Reasor, K. Dyke, 1995, Inflammation.

Lung Diseases in Surface , Underground Coal Mining and Stone Workers : Role of Silica and Calcium Causative Agents in Inflammatory Reactions Article Information

V. Castranova, K. Dyke, 2018 .

Analysis of oxidation of the membrane potential probe, Di-S-C3(5), during granulocyte activation

V. Castranova, K. Dyke, 1984 .

Calcium ionophore-stimulated chemiluminescence (CL) from human granulocytes: Evidence that A23187-induced chemiluminescence originates from arachidonic acid metabolism

V. Castranova, K. Dyke, C. V. Dyke, 1983 .

Therapy of Human Immunodeficiency Virus

K. Dyke, K. Woodfork, 2003 .

Studies of neonatal polymorphonuclear leukocyte function using a novel microanalytic chemiluminescence technique

A. Ardekani, W. Neal, D. Peden, 1986 .

An Automated Detection System for Most L-α-Amino Acids

K. Dyke, C. Szustkiewicz, 1969 .

Comparison of the effects of antioxidant non-steroidal anti-inflammatory drugs against myeloperoxidase and hypochlorous acid luminol-enhanced chemiluminescence

D. Peden, K. Dyke, D. English, 1982, Agents and Actions.

Antioxidation theory of non-steroidal anti-inflammatory drugs based upon the inhibition of luminol-enhanced chemiluminescence from the myeloperoxidase reaction

D. Peden, K. Dyke, D. English, 2005, Agents and Actions.

Delayed luminescence analysis (DLA) of purine and pyrimidine ribose and deoxyribose nucleotide triphosphates in picomole quantities

K. Dyke, M. Manandhar, 1974 .

Guanosine tetra- and pentaphosphate analysis

K. Dyke, 1975 .

Luminol-dependent chemiluminescence analysis of opsonophagocytic dysfunctions

W. Neal, M. Wilson, M. Trush, 1978 .

[39] The generation of chemiluminescence (CL) by phagocytic cells

M. Wilson, M. Trush, K. Dyke, 1978 .

Brief Note Plant Flavonoids and Nucleic Acid Synthesis in Human Leukocytes

K. Dyke, D. F. Blaydes, Michael Farrow, 1979 .

An efficient inexpensive multisleeve liquid scintillation counting system

M. Trush, K. Dyke, 1976 .

Purines and pyrimidines in malarial parasites. Commentary.

K. Dyke, 1990 .

Antimalarial Activity of Various Bisbenzylisoquinoline and AporphineBenzylisoquinoline Alkaloids and their Structure-Activity Relationships against Chloroquine Sensitive and Resistant Plasmodium falciparum Malaria in vitro

K. Dyke, Z. Ye, 2015 .

Luminol-dependent chemiluminescence analysis of cellular and humoral defects of phagocytosis using a chem-glo photometer

P. R. Miles, M. Wilson, M. Trush, 1977 .

Myeloperoxidase involvement in PMA-induced chemiluminescence in retinoic-acid-differentiated HL-60 cells

A. Ardekani, K. Dyke, 1989 .

The effect of plant growth substances and natural products on RNA and DNA synthesis in leukocytes

K. Dyke, M. G. Farrow, D. F. Blaydes, 1976, Experientia.

Antiviral drugs

K. Dyke, K. Woodfork, 2018, Reactions weekly.

The possible role of peroxynitrite in Alzheimer's disease: a simple hypothesis that could be tested more thoroughly

K. Dyke, 1997 .

Luminescence biotechnology : instruments and applications

Knox Van Dyke, Christopher Van Dyke, Karen Woodfork, 2001 .

A More Effective Method to Prevent or Control Diabetes and Alzheimer's Disease

K. Dyke, 2017 .

Luminescence Reveals the Possible Cause of Diabetes 1 , 2

R. Hoeldtke, K. Dyke, 2017 .

Bioluminescence and chemiluminescence : instruments and applications

Knox Van Dyke, K. Dyke, 1985 .

L-Arginine Levels among Hypertensive Patients in Sokoto, North Western Nigeria

K. Dyke, M. Imoru, A. Okwesili, 2017 .

PRELIMINARY EVENTS LEADING TO THE PRODUCTION OF LUMINOL-DEPENDENT CHEMILUMINESCENCE BY HUMAN GRANULOCYTES

V. Castranova, D. Peden, K. Dyke, 1981 .

Use of the luciferin-luciferase system to measure serum magnesium

K. Dyke, E. Flink, Robert A. Nuzem, 1979 .

Luminol- or lucigenin-coated micropolystyrene beads, a single reagent to study opsonin-independent phagocytosis by cellular chemiluminescence: Reaction with human neutrophils, monocytes, and differentiated HL60 cells

A. Ardekani, Lixin Wu, Jorge A. Garcia, 1990 .

A New ScreeningSystemfor Nonsteroidal Anti-Inflammatory Drugs BaseduponInhibition of Chemiluminescence Produced fromHuman Cells(Granulocytes)

M. Wilson, K. Dyke, 1979 .

Inhibition by nonsteroidal antiinflammatory drugs of luminol-dependent human-granulocyte chemiluminescence and [3H]FMLP binding

V. Castranova, D. Peden, Joseph K. H. Ma, 1982, Inflammation.

The incredible costs of chronic diseases: Why they occur and possible preventions and/or treatments

K. Dyke, 2016 .

Streptozotocin Generates Peroxynitrite Luminescence Which Reveals the Probable Cause of Diabetes 1 , 2 and 3 ( Alzheimer ’ s disease )

W. Geldenhuys, A. Robart, K. Dyke, 2017 .

A novel method for measuring initial-burst chemiluminescence in a liquid scintillation counter using the myeloperoxidase-H20Cl− reaction

D. Peden, K. Dyke, G. Pekoe, 1982 .

Purification of human granulocytes by centrifugal elutriation and measurement of transmembrane potential

V. Castranova, K. Dyke, G. S. Jones, 1980, Journal of cellular physiology.

Studies of luminol-dependent whole-blood chemiluminescence induced by platelet-activating factor (PAF)

V. Castranova, D. Peden, K. Dyke, 1985 .

Accelerated tissue aging and increased oxidative stress in broiler chickens fed allopurinol.

H. Klandorf, K. Dyke, K. Van Dyke, 2001, Comparative biochemistry and physiology. Toxicology & pharmacology : CBP.

Silica-Induced Pulmonary Inflammation in Rats: Activation of NF-κB and Its Suppression by Dexamethasone

V. Castranova, X. Shi, D. Porter, 1998 .

Multipurpose radiomatic automated flow liquid scintillation counter system for measurement of burst or delayed chemiluminescence reactions: Model-drug inhibition with luminol-dependent myeloperoxidase

V. Castranova, D. Peden, K. Dyke, 1982 .

Response of alveolar macrophages to in vitro exposure to freshly fractured versus aged silica dust: the ability of Prosil 28, an organosilane material, to coat silica and reduce its biological reactivity.

V. Castranova, N. Dalal, V. Vallyathan, 1991, Journal of toxicology and environmental health.

Chemiluminescent response in murine peritoneal macrophage hybridoma-cell line (2C11-12) primed with lipopolysaccharide or interferon β

A. Ardekani, K. Dyke, P. Debaetselier, 1989 .

Plasmodium falciparum: synthesis of glycoprotein by cultured erythrocytic stages.

K. Dyke, K. Van Dyke, I. Udeinya, 1981, Experimental parasitology.

The inhibition of silica-induced lung inflammation by dexamethasone as measured by bronchoalveolar lavage fluid parameters and peroxynitrite-dependent chemiluminescence

Lixin Wu, J. Antonini, M. Reasor, 1994, Agents and Actions.